Skip to content
#software testing Open access

bioq: a unified, agent-native command-line interface to a fleet of AI drug-discovery methods

Unknown authors
Sep 2026 · bioRxiv · 0 citations · 24 references
Biology

Abstract

Artificial intelligence methods now span the drug-discovery pipeline—structure prediction, de novo design, docking, affinity estimation, and ADMET—yet each tool ships with its own, often incompatible, GPU software stack, so chaining several into a workflow requires reproducing conflicting software environments and access to datacenter-class hardware that most labs do not have. bioq is a dependency-light command-line client backed by bioq-services (a control-plane gateway plus a growing fleet of 38+ containerized drug-discovery tools spanning 7 discovery stages and 6 molecular modalities). The bioq CLI is self-describing and consistent across the fleet of computational tools, giving researchers and coding agents uniform access to any tool from a laptop, with no local model code, CUDA setup, or cloud configuration, running on serverless GPUs billed per job. The interface–gateway–services architecture makes bioq an execution substrate for automated, agent-driven discovery. bioq and bioq-services are open source under the MIT License and available at https://github.com/wolfsonliu/bioq and https://github.com/wolfsonliu/bioq-services. bioq runs on Python ≥ 3.10 with httpx as its only runtime dependency; services run as Linux containers and are self-hostable via the provided local deployment scripts (alongside scripts for Alibaba Cloud Function Compute). Install, quickstart, test data, and self-hosting instructions are in the repository. The project is actively maintained and will continue to receive updates to both features and services.

Read PDF

Similar papers

#small language model Open access Sep 2026

DDA: a traceable multi-agent framework for automated structure-based drug design

Results indicate that DDA provides a scalable, executable, and traceable computational framework that reduces manual coordination in structure-based automated drug discovery and delivers prioritized candidate sets with minimal human intervention.

Yu-Tao Yu, Si-Cheng Tian, Guo-Hua Wang et al. · 0 citations
#small language model Open access Sep 2026

MolecureAI: an agentic AI platform for autonomous drug discovery

Accelerating the identification of viable drug candidates across therapeutic areas demands autonomous systems for molecular generation that enforce chemical correctness by structural invariants rather than model capability. We present MolecureAI, an autonomous AI agent architecture for closed-loop drug discovery with c...

M. Chadi, Asmaa Amzil, Hajar Ezzahoud et al. · 0 citations
Preprint Aug 2026

ALKEMIE Agent: an autonomous platform for computational materials design

ALKEMIE Agent is introduced, an agentic platform in which retrieval-augmented generation, a materials-computation knowledge base, registered skills, database-supported provenance, AI-assisted structure modeling, bounded task execution, tool-calling iteration, and error-diagnostic assistance are integrated within a trac...

Hongfu Huang, Yu-Zhe Li, Ao Xu et al. · 1 citation
#artificial intelligence Preprint Sep 2026

ASCEND: Personal AI Agents for Autonomous Scientific Computing Across HPC Clusters and GPU Workstations

ASEND (Autonomous Scientific Computing Engine and Novel Discovery), an AI-powered agent system, operated through a command-line or a local web chat interface, that runs the agent on the researcher's own laptop, reaching Slurm clusters and a GPU workstation over multiplexed authenticated SSH, with site-specific executio...

J. P. Liu, Uthpala Herath, Andrew Petersen · 0 citations
Sep 2026

SilicoXplore: An integrated cloud platform coupling machine learning with physics-based modelling for end-to-end drug discovery, applied to the computational prioritisation of putative New Delhi metallo-β-lactamase-1 binders.

Modern drug discovery joins machine learning with physics-based simulation, but building such a pipeline needs Linux administration, dependency management, format conversion and scripting, which keeps out many of the chemists and biologists who ask the questions. We describe SilicoXplore, a cloud-hosted platform of 31...

Parth Mangal, O. Shinde, Sonali Chikhale et al. · 0 citations

Related blog posts

Microsoft Research Blog Oct 30, 2026

From synthetic enterprise data evaluations to real Microsoft Copilot AI confidence

Evaluating Microsoft Copilot at enterprise scale requires test data that captures the full complexity of real organizations, yet real enterprise data contains sensitive information that cannot be used for evaluation under any circumstances. The post From synthetic enterprise data evaluations to real Microsoft Copilot AI confidence appeared first on Microsoft Research.

Microsoft Research Blog Oct 29, 2026

Microsoft Research Focus – Edition #97

Host Sowbhagya Suresh shares some of the latest news and cutting-edge research from across Microsoft—from understanding the challenges facing coding agents to uncovering how people use AI at work and improving extended-range weather forecasting. The post Microsoft Research Focus – Edition #97 appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.